BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oba A, Mise Y, Ito H, Hiratsuka M, Inoue Y, Ishizawa T, Arita J, Matsueda K, Takahashi Y, Saiura A. Clinical implications of disappearing colorectal liver metastases have changed in the era of hepatocyte-specific MRI and contrast-enhanced intraoperative ultrasonography. HPB 2018;20:708-714. [DOI: 10.1016/j.hpb.2018.02.377] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Anselmo A, Cascone C, Siragusa L, Sensi B, Materazzo M, Riccetti C, Bacchiocchi G, Ielpo B, Rosso E, Tisone G. Disappearing Colorectal Liver Metastases: Do We Really Need a Ghostbuster? Healthcare 2022;10:1898. [DOI: 10.3390/healthcare10101898] [Reference Citation Analysis]
2 Chang GY, Fetzer DT, Porembka MR. Contrast-Enhanced Intraoperative Ultrasound of the Liver. Surgical Oncology Clinics of North America 2022. [DOI: 10.1016/j.soc.2022.06.007] [Reference Citation Analysis]
3 Lin Y, Bale R, Brock KK, Odisio BC. Contemporary evidence on colorectal liver metastases ablation: toward a paradigm shift in locoregional treatment. International Journal of Hyperthermia 2022;39:649-63. [DOI: 10.1080/02656736.2021.1970245] [Reference Citation Analysis]
4 Nivolli A, Barabino E, Lacelli F, Arnò M, Ivaldi D, Pittaluga G, Percivale A, Gazzo P. Percutaneous microwave ablation of disappearing colorectal liver metastases using US-MR fusion imaging guidance with integration of pre-chemotherapy imaging: a case report. Current Problems in Cancer: Case Reports 2022. [DOI: 10.1016/j.cpccr.2022.100159] [Reference Citation Analysis]
5 Germani MM, Borelli B, Boraschi P, Antoniotti C, Ugolini C, Urbani L, Morelli L, Fontanini G, Masi G, Cremolini C, Moretto R. The management of colorectal liver metastases amenable of surgical resection: How to shape treatment strategies according to clinical, radiological, pathological and molecular features. Cancer Treat Rev 2022;106:102382. [PMID: 35334281 DOI: 10.1016/j.ctrv.2022.102382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ivey GD, Johnston FM, Azad NS, Christenson ES, Lafaro KJ, Shubert CR. Current Surgical Management Strategies for Colorectal Cancer Liver Metastases. Cancers (Basel) 2022;14:1063. [PMID: 35205811 DOI: 10.3390/cancers14041063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Baghdadi A, Mirpour S, Ghadimi M, Motaghi M, Hazhirkarzar B, Pawlik TM, Kamel IR. Imaging of Colorectal Liver Metastasis. J Gastrointest Surg 2022;26:245-57. [PMID: 34664191 DOI: 10.1007/s11605-021-05164-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Lin Y, Odisio BC, Sofocleous CT. Radiofrequency Ablation, Electroporation, and Microwave Ablation. Colorectal Liver Metastasis 2022. [DOI: 10.1007/978-3-031-09323-4_41] [Reference Citation Analysis]
9 Torzilli G. Intraoperative Ultrasound. Colorectal Liver Metastasis 2022. [DOI: 10.1007/978-3-031-09323-4_52] [Reference Citation Analysis]
10 Hewitt DB, Pawlik TM. Disappearing Liver Metastasis. Colorectal Liver Metastasis 2022. [DOI: 10.1007/978-3-031-09323-4_23] [Reference Citation Analysis]
11 Fergadi MP, Magouliotis DE, Vlychou M, Rountas C, Athanasiou T, Zacharoulis D. A meta-analysis evaluating contrast-enhanced intraoperative ultrasound (CE-IOUS) in the context of surgery for colorectal liver metastases. Abdom Radiol (NY) 2021;46:4178-88. [PMID: 33969446 DOI: 10.1007/s00261-021-03096-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Lin YM, Paolucci I, Brock KK, Odisio BC. Image-Guided Ablation for Colorectal Liver Metastasis: Principles, Current Evidence, and the Path Forward. Cancers (Basel) 2021;13:3926. [PMID: 34439081 DOI: 10.3390/cancers13163926] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Li C, Liu Y, Xu J, Song J, Wu M, Chen J. Contrast-Enhanced Intraoperative Ultrasonography with Kupffer Phase May Change Treatment Strategy of Metastatic Liver Tumors - A Single-Centre Prospective Study. Ther Clin Risk Manag 2021;17:789-96. [PMID: 34366666 DOI: 10.2147/TCRM.S317469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Oba A, Inoue Y, Ono Y, Ishizuka N, Arakaki M, Sato T, Mise Y, Ito H, Saiura A, Takahashi Y. Staging laparoscopy for pancreatic cancer using intraoperative ultrasonography and fluorescence imaging: the SLING trial. Br J Surg 2021;108:115-8. [PMID: 33711121 DOI: 10.1093/bjs/znaa111] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Liu W, Zhang ZY, Yin SS, Yan K, Xing BC. Contrast-Enhanced Intraoperative Ultrasound Improved Sensitivity and Positive Predictive Value in Colorectal Liver Metastasis: a Systematic Review and Meta-Analysis. Ann Surg Oncol 2021;28:3763-73. [PMID: 33247361 DOI: 10.1245/s10434-020-09365-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Barimani D, Kauppila JH, Sturesson C, Sparrelid E. Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review. World J Surg Oncol 2020;18:264. [PMID: 33032620 DOI: 10.1186/s12957-020-02037-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
17 Hata T, Mise Y, Ono Y, Sato T, Inoue Y, Ito H, Takahashi Y, Yanaga K, Saiura A. Multidisciplinary treatment for colorectal liver metastases in elderly patients. World J Surg Oncol 2020;18:173. [PMID: 32680531 DOI: 10.1186/s12957-020-01950-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Riediger C, Plodeck V, Fritzmann J, Pape A, Kohler A, Lachmann B, Koch T, Kühn JP, Hoffmann RT, Weitz J. First application of intraoperative MRI of the liver during ALPPS procedure for colorectal liver metastases. Langenbecks Arch Surg 2020;405:373-9. [PMID: 32458140 DOI: 10.1007/s00423-020-01890-3] [Reference Citation Analysis]
19 Mao Y, Chen B, Wang H, Zhang Y, Yi X, Liao W, Zhao L. Diagnostic performance of magnetic resonance imaging for colorectal liver metastasis: A systematic review and meta-analysis. Sci Rep 2020;10:1969. [PMID: 32029809 DOI: 10.1038/s41598-020-58855-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
20 Oba A, Inoue Y, Ono Y, Irie S, Sato T, Mise Y, Ito H, Takahashi Y, Saiura A. Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection? Langenbecks Arch Surg 2020;405:35-41. [DOI: 10.1007/s00423-019-01846-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
21 Araujo RLC, Milani JM, Armentano DP, Moreira RB, Pinto GSF, de Castro LA, Lucchesi FR. Disappearing colorectal liver metastases: Strategies for the management of patients achieving a radiographic complete response after systemic chemotherapy. J Surg Oncol. 2020;121:848-856. [PMID: 31773747 DOI: 10.1002/jso.25784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
22 Vernuccio F, Dioguardi Burgio M, Barbiera F, Cusmà S, Badalamenti G, Midiri M, Vilgrain V, Brancatelli G. CT and MR imaging of chemotherapy-induced hepatopathy. Abdom Radiol (NY) 2019;44:3312-24. [PMID: 31435760 DOI: 10.1007/s00261-019-02193-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
23 Pöhler GH, Ringe KI. [Computed tomography and/or magnetic resonance imaging of the liver : How, why, what for?]. Radiologe 2019;59:804-11. [PMID: 31414150 DOI: 10.1007/s00117-019-00583-3] [Reference Citation Analysis]
24 Tsilimigras DI, Ntanasis-Stathopoulos I, Paredes AZ, Moris D, Gavriatopoulou M, Cloyd JM, Pawlik TM. Disappearing liver metastases: A systematic review of the current evidence. Surg Oncol. 2019;29:7-13. [PMID: 31196496 DOI: 10.1016/j.suronc.2019.02.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]